Figures
Abstract
Background
Transgender persons are highly victimized, marginalized, disproportionately experience incarceration, and have alarmingly increased rates of HIV infection compared to cis-gender persons. Few studies have examined the HIV care continuum outcomes among transgender women (TW), particularly TW who are involved with the criminal justice (CJ) system.
Methods
To improve our understanding of HIV care continuum outcomes and risk behaviors among HIV-infected TW who are involved with the CJ system, we analyzed data from the National Institute on Drug Abuse-supported Seek, Test, Treat, Retain (STTR) Data Harmonization Initiative. Baseline data were pooled and analyzed from three U.S. STTR studies to examine HIV risk and care continuum indicators among CJ-involved HIV-infected TW compared to cisgender men (CM), matched on age (within 5 years) and study at a ratio of 1:5.
Results
Eighty-eight TW and 440 CM were included in the study. Among matched participants, TW were more likely to report crack and cocaine use compared to CM (40%,16% respectively, p<0.001); both TW and CM reported high rates of condomless sex (58%, 64%, respectively); TW were more likely than CM to have more than one sexual partner (OR = 2.9, 95% CI: 1.6, 5.2; p<0.001) and have engaged in exchange sex (OR = 3.9, 95% CI: 2.3, 6.6; p<0.001). There were no significant differences between TW and CM in the percentage currently taking ART (52%, 49%, respectively), the mean percent adherence to ART (77% for both groups), and the proportion who achieved viral suppression (61%, 58%, respectively).
Conclusions
HIV-infected CJ-involved TW and CM had similar use of ART and viral suppression but TW were more likely than matched CM to engage in exchange sex, have multiple sexual partners, and use crack/cocaine. TW and CM had similarly high rates of condomless sex and use of other drugs. TW require tailored risk reduction interventions, however both CJ-involved TW and CM require focused attention to reduce HIV risk and improve HIV continuum of care outcomes.
Citation: Beckwith CG, Kuo I, Fredericksen RJ, Brinkley-Rubinstein L, Cunningham WE, Springer SA, et al. (2018) Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization Initiative. PLoS ONE 13(5): e0197730. https://doi.org/10.1371/journal.pone.0197730
Editor: Paula Braitstein, University of Toronto Dalla Lana School of Public Health, CANADA
Received: December 13, 2017; Accepted: May 8, 2018; Published: May 22, 2018
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Data Availability: Due to the sensitive nature of data collected from participants, some participants of these studies were prisoners at the time of data collection, and individual data use agreements that exist between study sites and the Data Coordinating Center, data used in this study are not publicly available at this time. These restrictions on data access have been imposed by the University of Washington STTR Data Coordinating Center. However, data will be made available to qualified persons and data requests may be sent to the University of Washington STTR Data Coordinating Center (contact Erika Enright, email eenright@uw.edu).
Funding: Research presented in this paper is the result of secondary data analysis and was supported by 5U01DA037702 (University of Washington) from the National Institute on Drug Abuse (NIDA). Primary data collection was supported by grants R01DA030781 (Cunningham), R01DA030747 (Beckwith, Kuo), R01DA030796 (Zawitz). In addition, this research was supported by the Providence-Boston Center for AIDS Research [P30AI042853 (Beckwith)], R25DA037190 (Brinkley-Rubinstein), R25DA035692 (Brinkley-Rubinstein), R01DA030762 (Springer), R01DA032100 (Franks), R01DA030770 (Seal). The authors thank the other investigators, the staff, and particularly the participants of the individual STTR studies for their valuable contributions. A full list of participating STTR investigators and institutions can be found at http://www.sttr-hiv.org.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Transgender persons, defined as those whose current gender identity or expression differs from their assigned sex at birth [1], are a highly victimized, stigmatized, and socio-economically marginalized population [2–9]. They experience significant housing instability and twice the rates of poverty and unemployment compared to the general population of the United States (US) [8]. Transgender persons disproportionately experience incarceration compared to cis-gender persons (persons whose gender identity or expression is consistent with their assigned sex at birth), with 1 in 5 transgender women (TW) reporting at least one previous incarceration [10, 11]. Transgender individuals are also at extreme risk of HIV infection, with 28% of TW testing positive [12]; a rate 34 times higher than the general US adult population [13], with alarmingly high rates of infection among Black TW [13, 14].
In general, there is relatively limited data describing HIV-related risk behaviors among TW. Estimates from one study conducted in Los Angeles County suggested that TW had high rates of substance use (alcohol, marijuana, and methamphetamines), lifetime injection drug use, and recent commercial sex work [14]. Another recent study in the San Francisco, CA area suggested that nearly 32% of TW participants had engaged in condomless receptive anal sex with a casual partner and 23% with commercial sex partners; and condomless receptive anal sex with commercial sex partners was more common among HIV-positive participants compared to HIV-negative participants [15].
Despite their marked vulnerability, relatively few studies have examined indicators of engagement in the HIV care continuum among TW, such as access to antiretroviral treatment (ART), ART adherence, and HIV viral suppression, and no studies have specifically looked at these HIV care indicators among TW who are involved in the criminal justice (CJ) system. This lack of data represents an important knowledge gap given TW are overrepresented in the criminal justice system, despite comprising a small percentage of the adult U.S. population [16]. In addition, while involved in CJ system, TW are often met with unsafe placement, harassment, assault, and lack of access to health care services [16].
Among studies that have examined HIV care continuum outcomes among TW, results have been varied and sometimes contradictory [9, 17–21], which may be in part due to heterogeneity between study populations and relatively small sample sizes. One study conducted in Florida suggested that TW enter HIV care later than cisgender women and with more advanced disease (i.e., diagnosed with AIDS within 3 months of their HIV diagnosis) [17]. Conversely, two multi-site studies conducted in the U.S. found TW had similar levels of HIV viral suppression when compared to cisgender HIV-infected persons [18, 19]. However, other studies including both multi-site [9] and single site studies conducted in California [20, 21] have found that TW are less likely to achieve viral suppression. Beyond the HIV care continuum, there appear to be disparities related to the quality of HIV care; a large US study found HIV-infected TW reported significantly fewer positive interactions with their healthcare providers compared to cisgender persons [22].
There is a clear and consistent link between social and economic marginalization, violent and sexual victimization, and HIV treatment outcomes among TW [23]. A recent study found housing instability to be associated with poor HIV treatment outcomes among TW [21]. Structural barriers, such as lack of employment and decreased access to food or housing, have also been associated with condomless anal sex and increased victimization among HIV-negative TW [24]. A global meta-analysis found that TW required more intensive supportive services and higher percentages of TW needed basic services such as food and housing assistance compared to HIV-infected cisgender persons [8].
To improve our understanding of HIV care continuum outcomes and risk behaviors among HIV-infected TW who are involved with the CJ system, we analyzed data from the multi-study National Institute on Drug Abuse-supported Seek, Test, Treat, Retain (STTR) Data Harmonization Initiative. HIV risk and care continuum indicators among CJ-involved HIV-infected TW were compared to CJ-involved HIV-infected CM.
Materials and methods
Data for these analyses were collected from three separate studies within the STTR consortium (https://sttr-hiv.org/). The consortium’s goal is to integrate data from multiple studies to address research questions related to HIV care continuum outcomes among vulnerable populations that require larger sample sizes than the individual studies provided [25]. The consortium has harmonized data from numerous independent STTR research studies on multiple domains including: demographic information, substance use, criminal justice (CJ) status, ART adherence, HIV risk behaviors (e.g., condomless sex, injection drug use), and HIV care continuum outcomes including HIV viral suppression defined as an HIV viral load (VL) of ≤ 200 copies/ml. To conduct these analyses, data were pooled from three STTR studies (Table 1) that met the following criteria:1) enrolled a minimum of five HIV-infected TW; 2) enrolled HIV-infected CM; 3) collected data on the majority of the domains of interest at the study baseline assessment, and 4) were conducted in the US. All three of the studies focused specifically on CJ-involved participants, including two studies that recruited participants in CJ-based settings (prisons, jails, detention centers, and persons under community supervision, e.g. probation or parole status), and one study that recruited participants after release from jail.
Herein, we briefly summarize the study populations and sites of recruitment. The LINK LA Study and CARE+ Corrections studies have been described in detail elsewhere [26, 27]. The LINK LA study recruited HIV-infected men and TW who were incarcerated in the LA County jail system and who were referred to the transitional case management program. Participants were 18 years of age or older, English or Spanish speaking, and eligible for ART. LINK LA enrolled 356 participants from 2012–2016. The CARE+ Corrections study recruited HIV-infected persons who were 18 years or age or older, English speaking, and who were incarcerated in Washington D.C. Department of Corrections facilities or recently incarcerated (within the previous six months). CARE+ Corrections enrolled 112 participants between 2013–2015. The STT Jail study recruited HIV-infected persons who were 18 years of age or older, English-speaking, and who were anticipated to be released from the Cook County Jail within six months. STT Jail enrolled 460 participants between 2013–2016.
Information on age, race and ethnicity, education, homelessness, health insurance, ART adherence measured though the Visual Analogue Scale (VAS) [28], and use of alcohol and illicit drugs was collected during the baseline assessments for each study. Except for age, race and ethnicity, and education, participants were asked to report risk behaviors and engagement in HIV treatment during a specific reference period which varied by study and in some cases by behavior within study (i.e., 30, 90, or 180 days prior to incarceration for current detainees or those recently released from incarceration). In studies where the baseline survey was administered in the community, CJ supervision status was collected by self-report or from CJ administrative records. Risk behavior questionnaires elicited information regarding participants’ sexual and drug using risk behaviors during each study’s reference period. Specifically, participants were asked about their engagement in vaginal or anal intercourse, condom use, number of sexual partners, and exchange sex (defined as having sex to receive money, alcohol, drugs, or other things). Participants were asked about any use of alcohol, binge alcohol, marijuana, crack/cocaine, opioids, stimulants, other substances, multiple substances; hazardous drinking was assessed using the AUDIT-C [29]. HIV VL was assessed through laboratory testing performed by the study or review of recent medical records.
Using a risk set sampling approach, all eligible TW from the three studies were selected and matched at a ratio of 1:5 to CM participants on age (within 5 years) and study. While each of the five CM participants matched to a TW participant were unique individuals, CM participants were eligible to be randomly sampled as controls for multiple TW for whom they met the matching criteria. A total of 88 TW and 440 CM were included in the study. Conditional logistic regression was used to test for differences between matched TW and CM participants in risk behaviors and HIV care outcomes represented as binary variables. Differences in characteristics represented as continuous variables were tested using generalized linear models with robust standard errors. P-values < 0.05 were considered statistically significant.
The studies were approved by the following institutional review boards: The University of California, Los Angeles (LINK LA), Los Angeles County Department of Public Health (LINK LA), George Washington University (CARE+ Corrections), The Miriam Hospital (CARE+ Corrections), University of Illinois at Chicago (STT Jail), and the Cook County Health and Hospitals System (STT Jail). Additional protections were provided by the Office of Human Research Protections at the Department of Health and Human Services, and Certificates of Confidentiality were obtained.
Results
Table 2 displays demographic characteristics of study participants, stratified by study and gender. Overall, the mean age across groups was 35 years (±10), 53% were Black, and 23% were Hispanic. A slightly higher proportion of TW reported being homeless compared to CM (49% and 41% respectively), while similar proportions of TW (43%) and CM (39%) reported not having health insurance.
As outlined in Table 3, any alcohol use and binge drinking were common across all studies and groups, with more than one-half of all respondents reporting any alcohol use. Across individual studies, between 25% and 69% reported binge drinking. From the two studies that measured hazardous drinking, the overall proportion of TW and CM participants classified as hazardous drinkers was 42% and 40%, respectively. Overall, marijuana and stimulant use was common, although the range of use of these substances varied greatly across studies. For crack and cocaine use, the proportion of use also varied across studies, but overall, TW were more likely to report crack and cocaine use compared to CM (40% and 16% respectively, p<0.001). Opioid use across all studies and among TW and CM was relatively low compared to the other substances (13% and 15%, respectively). TW were more likely than CM to use multiple substances defined as using ≥ 2 substances (including alcohol) (74% and 62% respectively, p = 0.04).
Table 4 displays sexual risk behaviors reported by study participants. Both TW and CM reported high rates of condomless sex (58% and 64%, respectively; p = 0.37). TW were significantly more likely than CM to have more than one sexual partner (OR = 2.9, 95% CI: 1.6, 5.2; p<0.001) and have engaged in exchange sex (OR = 3.9, 95% CI: 2.3, 6.6; p<0.001).
Table 5 displays HIV care continuum outcomes reported by study participants. Overall, there was no significant difference between TW and CM in the percentage currently taking ART, with 52% of TW and 49% of CM on ART (OR = 1.1; 95% CI: 0.7–1.8, p = 0.6). Similarly, there were no significant differences between TW and CM in the mean percent adherence to ART (77% for both groups), the proportion who achieved viral suppression (61% and 58%, respectively), or the proportion who had CD4 counts ≤ 200 compared to CM (OR = 0.4; 95% CI: 0.1–2.1, p = 0.30).
Discussion
This study among HIV-infected persons in the CJ system found no significant difference between TW and CM in the use of ART, reported adherence to ART, or with achieving viral suppression. Approximately one-half of our study population reported being on ART at the time of baseline data collection and close to 60% were found to have viral suppression. The proportion receiving ART was similar to the results among jailed persons in a recent systematic review that indicated 51% of persons were on ART during incarceration which decreased to 29% after release, and 40% achieved viral suppression during incarceration which decreased to 21% after release [30]. One explanation for our findings may be that both TW and CM were better able to access HIV care and treatment during periods of incarceration compared to when residing in the community, thus attenuating any potential differences that may exist outside of the correctional setting. We were not able to assess changes in ART use or viral suppression following release from correctional facilities in this study, but other studies have demonstrated decreased ART use and consequent viral rebound during community re-entry [30–33].
In our study, TW were more likely to engage in several HIV transmission behaviors compared to age-matched CM from the same studies. While both TW and CM reported high rates of condomless sex, TW were more likely than CM to have multiple sexual partners and to engage in exchange sex. Similarly, high rates of substance use were reported among both TW and CM, but the proportion of TW using crack/cocaine was more than twice as high as that of CM. Despite TW reporting higher rates of engagement in HIV transmission behaviors, both populations had similarly sub-optimal HIV continuum of care outcomes including ART use, ART adherence, and viral suppression. These findings suggest that interventions to improve HIV care engagement and viral suppression in both TW and CM are needed, but that TW would especially benefit from gender-tailored interventions that address their unique vulnerabilities and risk behaviors.
In both TW and CM, rates of condom use and ART were low while rates of substance use were high. Substance use disorders have been linked to both high risk HIV transmission behaviors and poor retention in HIV care [34, 35], including among TW [36, 37]. The sub-optimal outcomes in this sample of CJ-involved TW and CM are particularly concerning given that incarceration is often viewed as an opportunity to re-engage people living with HIV in care [38, 39]. These findings speak to the need for innovative methods that support retention in HIV care and HIV prevention efforts, including the expansion of case management services, ART adherence counseling, and comprehensive substance abuse treatment services.
The TW in this study were uniquely vulnerable due to higher rates of crack/cocaine use than CM. There are no approved pharmacotherapies for cocaine use disorders; cognitive behavioral therapy is currently the only approved management option and is often unavailable to socially disenfranchised populations such as TW. In addition, high rates of exchange sex and cocaine use in TW may be intertwined, where TW may be more likely to find themselves needing to engage in exchange sex to support their addiction. Approximately 40% of TW and CM in this study reported stimulant use. Previously published studies of female sex workers and men who have sex with men (MSM) have revealed patterns of stimulant use during sexual encounters were attributed to a number of factors, including sexual enhancement, increased energy levels, and as a coping mechanism during exchange sex [40, 41]. To reduce risk behaviors and improve HIV continuum of care outcomes among TW and CM, new approaches to treat cocaine and stimulant use disorders are needed and the development of new behavioral and pharmacological interventions must be a research priority. Importantly, TW require substance abuse treatment programs that are non-judgmental, inclusive of their gender and sexual orientation, and that address other co-occurring needs such as lack of social support, stigma, and frequent history of abuse and harassment [42].
The differences in sexual risk behaviors and substance use patterns between TW and CM suggest that there may be opportunities to reduce transmission of HIV and improve treatment outcomes through gender-tailored interventions [43]. While condom use was similar between populations (36–42%), TW were more likely to have multiple sexual partners, which creates a higher risk of HIV transmission when only 42% of HIV-infected TW reported consistently using condoms. Thus, it is particularly important to prioritize interventions that can improve condom use as well as optimize ART adherence and viral suppression in TW [44]. Relatedly, TW were almost 4 times more likely to engage in exchange sex. TW have historically been socially marginalized and stigmatized in ways that may increase their likelihood of engaging in commercial sex work [7, 23, 45]. While TW appear to be accessing HIV care at rates similar to CM, their engagement in exchange sex indicates a social vulnerability that can influence their continued access to care and ability to negotiate condom use [23, 46]. Future interventions targeting TW should acknowledge the contextual factors relevant to TW that can affect HIV risk behavior such as gender-based power imbalances, stigma, increased risk of interpersonal or sexual violence, financial vulnerability, and the work environment (e.g. public vs. indoor) when engaging in exchange sex [47–52].
There were limitations to this study. Two of the three STTR studies included recruited persons inside correctional facilities, which may have influenced HIV treatment outcomes since these persons may have better access to HIV treatment than persons enrolled in the community. This study was a secondary analysis of cross-sectional data collected through the STTR consortium, hence, the three studies included were heterogeneous in terms of study design, eligibility criteria, geographic location, and the reference periods used for assessing baseline substance use and sexual risk behaviors. While this may limit the robustness of our findings, the geographic heterogeneity provided a more nationally representative sample than single-site studies. Furthermore, the use of matching in the analysis ensured that comparisons were made between TW and CM within the same study, thus between-study differences cannot account for the observed differences between TW and CM risk behaviors. Including cisgender women as a comparison group in the analysis would have enhanced the study, but not all of the studies included in this analysis recruited cisgender women. Similarly, not all of the studies collected information on sexual orientation, thus we were unable to identify MSM. If the majority of CM in this study were MSM, a group that also experiences high rates of stigma and substance use, this may have attenuated differences between the TW and CM than may have been observed if the TW were compared to non-MSM HIV-infected men.
In conclusion, we found that CJ-involved HIV-infected TW, as compared to CJ-involved HIV-infected CM, had similar HIV continuum of care outcomes but TW were more likely to engage in exchange sex, have multiple sexual partners, and use crack/cocaine or multiple substances. Nevertheless, TW and CM had similarly high rates of condomless sex and use of illicit drugs and other substances. These results indicate that TW require population-specific interventions that address specific HIV transmission behaviors and are also sensitive to the unique barriers to care and psychosocial vulnerabilities that many TW experience. In general, though, interventions are needed for both CM and TW that target condomless sex, substance use behaviors, and engagement in HIV care to improve HIV-related outcomes.
References
- 1.
Transgender terminology: National Center for Transgender Equality. Available from: http://www.transequality.org/issues/resources/transgender-terminology.
- 2. Shires DA, Jaffee KD. Structural discrimination is associated with smoking status among a national sample of transgender individuals. Nicotine Tob Res. 2016;18(6):1502–8. pmid:26438646
- 3. Langenderfer-Magruder L, Walls NE, Kattari SK, Whitfield DL, Ramos D. Sexual victimization and subsequent police reporting by gender identity among lesbian, gay, bisexual, transgender, and queer adults. Violence Vict. 2016;31(2):320–31. pmid:26831853
- 4. White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31. pmid:26599625
- 5. Lombardi EL, Wilchins RA, Priesing D, Malouf D. Gender violence: transgender experiences with violence and discrimination. J Homosex. 2001;42(1):89–101. pmid:11991568
- 6. Dank M, Lachman P, Zweig JM, Yahner J. Dating violence experiences of lesbian, gay, bisexual, and transgender youth. Journal of youth and adolescence. 2014;43(5):846–57. pmid:23861097
- 7. Nemoto T, Bodeker B, Iwamoto M. Social support, exposure to violence and transphobia, and correlates of depression among male-to-female transgender women with a history of sex work. Am J Public Health. 2011;101(10):1980–8. pmid:21493940
- 8.
National Center for Transgender Equality NGaLTF. National Transgender Discrimination Survey: Preliminary Findings. 2009.
- 9. Mizuno Y, Frazier EL, Huang P, Skarbinski J. Characteristics of Transgender Women Living with HIV Receiving Medical Care in the United States. LGBT Health. 2015;2(3):228–34. pmid:26788671
- 10. Salazar LF, Crosby RA, Jone J, Kota K, Hill B, Masyn KE. Contextual, experiential, and behavioral risk factors associated with HIV status: a descriptive analysis of transgender women residing in Atlanta, Georgia. Int J STD AIDS. 2017;11:1059–1066.
- 11. Reisner SL, Bailey Z, Sevelius J. Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S. Women Health 2014;54: 750–67. pmid:25190135
- 12. Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav. 2008;12(1):1–17. pmid:17694429
- 13. Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22. pmid:23260128
- 14. Reback CJ, Fletcher JB. HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach. AIDS Behav. 2014;18(7):1359–67. pmid:24287786
- 15. Nemoto T, Bödeker B, Iwamoto M, Sakata M. Practices of receptive and insertive anal sex among transgender women in relation to partner types, sociocultural factors, and background variables. AIDS Care. 2014;26(4):434–40. pmid:24160715
- 16.
Movement Advancement Project. Unjust: How the broken criminal justice system fails transgender people. Available from http://www.lgbtmap.org/criminal-justice-trans.
- 17. Fennie KP, Trepka MJ, Maddox LM, Lutfi K, Lieb S. Comparison of individual and area level factors between HIV-infected cisgender and transgender individuals in Florida (2006–2014). AIDS Behav 2016;20(10):2186–91. pmid:26885811
- 18. Melendez RM, Exner TA, Ehrhardt AA, Dodge B, Remien RH, Rotheram-Borus MJ, et al. Health and health care among male-to-female transgender persons who are HIV positive. Am J Public Health. 2006;96(6):1034–7. pmid:16131645
- 19. Yehia BR, Fleishman JA, Moore RD, Gebo KA. Retention in care and health outcomes of transgender persons living with HIV. Clin Infect Dis. 2013;57(5):774–6. pmid:23723203
- 20. Baguso GN, Gay CL, Lee KA. Medication adherence among transgender women living with HIV. AIDS Care. 2016;28(8):976–81. pmid:26908228
- 21. Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5): 430–3. pmid:24714446
- 22. Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. JANAC. 2010;21(3):256–64. pmid:20347342
- 23. Smith LR, Yore J, Triplett DP, Urada L, et al. Impact of sexual violence across the lifespan on HIV risk behaviors among transgender women and cisgender people living with HIV. J Acquir Immune Defic Syndr. 2017;75 (4): 408–416. pmid:28653970
- 24. Raiford JL, Hall GJ, Taylor RD, Bimbi DS, Parsons JT. The role of structural barriers in risky sexual behavior, victimization and readiness to change HIV/STI-related risk behavior among transgender women. AIDS Behav. 2016;20(10): 2212–21. pmid:27167631
- 25. Chandler RK, Kahana SY, Fletcher B, Jones D, Finger MS, Aklin WM, et al. Data collection and harmonization in HIV research: the Seek, Test, Treat, and Retain initiative at the National Institute on Drug Abuse. Am J Public Health. 2015;105(12):2416–22. pmid:26469642
- 26. Cunningham WE, Weiss RE, Nakazono T, Malek MA, Shoptaw SJ, Ettner SL,et al. Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail. The LINK LA randomized clinical trial. JAMA Int Med. 2018. Published online March 12, 2018.
- 27. Beckwith C, Castonguay BU, Trezza C, Bazerman L, Patrick R, Cates A, et al. Gender Differences in HIV Care among Criminal Justice-Involved Persons: Baseline Data from the CARE+ Corrections Study. PLOS One. 2017. 12(1): p. e0169078. pmid:28081178
- 28. Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients. HIV Clin Trials, 2011;12(5): 244–54. pmid:22180522
- 29. Daeppen JB, Yersin B, Landry U, Pecoud A, Decrey H. Reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) imbedded within a general health risk screening questionnaire: results of a survey in 332 primary care patients. Alcohol Clin Exp Res. 2000;24(5): 659–65. pmid:10832907
- 30. Iroh PA, Mayo H, Nijhawan AE. The HIV cascade before, during, and after incarceration: A systematic review and data synthesis. Am J Pub Health 2015; 105: e5–e16.
- 31. Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–1760. pmid:15227623
- 32. Baillargeon JG, Giordano TP, Harzke AJ, Baillargeon G, Rich JD, Paar DP. Enrollment in outpatient care among newly released prison inmates with HIV infection. Public Health Rep. 2010; 125(suppl 1):64–71.
- 33. Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–731. pmid:21890777
- 34. Monroe AK, Lau B, Mugavero MJ, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016;73(4):419–25. pmid:27243904
- 35. Rowe C, Liou T, Vittinghoff E, Coffin PO, Santos GM. Binge drinking concurrent with anal intercourse and condom use among men who have sex with men. AIDS Care. 2016; 28(12):1566–70. pmid:27241085
- 36. Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, et al. Syndemic theory and HIV-related risk among young transgender women: The role of multiple, co-occurring health problems and social marginalization. Am J Pub Health. 2012; 102: 1751–1757.
- 37. Hotton AL, Garofalo R, Kuhns LM, Johnson AK. Substance use as a mediator of the relationship between life stress and sexual risk among young transgender women. AIDS Educ Prev. 2013; 25: 62–71. pmid:23387952
- 38. Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Int Med. 2014;174(5):721–9.
- 39. Draine J, Ahuja D, Altice FL, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011; 23(3):366–77. pmid:21347900
- 40. Diaz RM, Heckert AL, Sanchez J. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users. J Urban Health. 2005; 82(1 Suppl 1):i71–8.
- 41. Maher L, Phlong P, Mooney-Somers J, et al. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy. 2011; 22(3):203–9. pmid:21316935
- 42. Stevens S. Meeting the substance abuse treatment needs of lesbian, bisexual, and transgender women: implications from research to practice. Subst Abuse Rehabil. 2012: 3 (Suppl 1) 27–36. pmid:24474874
- 43. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16. pmid:24317955
- 44. Coleman SM, Rajabiun S, Cabral HJ, Bradford JB, Tobias CR. Sexual risk behavior and behavior change among persons newly diagnosed with HIV: the impact of targeted outreach interventions among hard-to-reach populations. AIDS Pt Care STDs. 2009;23(8):639–45.
- 45. Nemoto T, Iwamoto M, Perngparn U, Areesantichai C, Kamitani E, Sakata M. HIV-related risk behaviors among kathoey (male-to-female transgender) sex workers in Bangkok, Thailand. AIDS Care. 2012;24(2):210–9. pmid:21780964
- 46. Tan SY, Melendez-Torres GJ. A systematic review and metasynthesis of barriers and facilitators to negotiating consistent condom use among sex workers in Asia. Cult Health Sex. 2016;18(3):249–64. pmid:26325239
- 47. Handlovsky I, Bungay V, Kolar K. Condom use as situated in a risk context: women's experiences in the massage parlour industry in Vancouver, Canada. Cult Health Sex. 2012;14(9):1007–20. pmid:22900640
- 48. Horton KL, Dworkin SL. Redefining gender-based power to move beyond interpersonal approaches to HIV prevention. ANS Adv Nurs Sci. 2013;36(1):42–50. pmid:23370499
- 49. Krusi A, Chettiar J, Ridgway A, Abbott J, Strathdee SA, Shannon K. Negotiating safety and sexual risk reduction with clients in unsanctioned safer indoor sex work environments: a qualitative study. Am J Pub Health. 2012;102(6):1154–9.
- 50. Shannon K, Strathdee SA, Shoveller J, Rusch M, Kerr T, Tyndall MW. Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Pub Health. 2009;99(4):659–65.
- 51. Urada LA, Morisky DE, Pimentel-Simbulan N, Silverman JG, Strathdee SA. Condom negotiations among female sex workers in the Philippines: environmental influences. PLOS ONE. 2012;7(3):e33282. pmid:22448241
- 52. Wirtz AL, Schwartz S, Ketende S, et al. Sexual violence, condom negotiation, and condom use in the context of sex work: results from two West African countries. J Acquir Immune Defic Syndr. 2015;68 Suppl 2:S171–9.